Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Deep Sequencing Reveals Central Nervous System Compartmentalization in Multiple Transmitted/Founder Virus Acute HIV-1 Infection.

Tovanabutra S, Sirijatuphat R, Pham PT, Bonar L, Harbolick EA, Bose M, Song H, Chang D, Oropeza C, O'Sullivan AM, Balinang J, Kroon E, Colby DJ, Sacdalan C, Hellmuth J, Chan P, Prueksakaew P, Pinyakorn S, Jagodzinski LL, Sutthichom D, Pattamaswin S, de Souza M, Gramzinski RA, Kim JH, Michael NL, Robb ML, Phanuphak N, Ananworanich J, Valcour V, Kijak GH, Sanders-Buell E, Spudich S; MHRP Viral Sequencing Core; RV254/SEARCH 010 Study Team.

Cells. 2019 Aug 15;8(8). pii: E902. doi: 10.3390/cells8080902.

PMID:
31443253
2.

HIV-1 genetic diversity and demographic characteristics in Bulgaria.

Billings E, Heipertz RA, Varleva T, Sanders-Buell E, O'Sullivan AM, Bose M, Howell S, Kijak GH, Taskov H, Elenkov I, Nenova M, Popivanova N, Valenzuela AB, Myles O, Bautista CT, Robb ML, Michael NL, Kim JH, Scott PT, Tovanabutra S, Ake JA.

PLoS One. 2019 May 28;14(5):e0217063. doi: 10.1371/journal.pone.0217063. eCollection 2019.

3.

New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men.

Billings E, Kijak GH, Sanders-Buell E, Ndembi N, OʼSullivan AM, Adebajo S, Kokogho A, Milazzo M, Lombardi K, Baral S, Nowak R, Ramadhani H, Gramzinski R, Robb ML, Michael NL, Charurat ME, Ake J, Crowell TA, Tovanabutra S; MHRP Viral Sequencing Core and the TRUST/RV368 Study Group.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):578-584. doi: 10.1097/QAI.0000000000002076.

PMID:
31107298
4.

Next-generation sequencing of HIV-1 single genome amplicons.

Kijak GH, Sanders-Buell E, Pham P, Harbolick EA, Oropeza C, O'Sullivan AM, Bose M, Beckett CG, Milazzo M, Robb ML, Peel SA, Scott PT, Michael NL, Armstrong AW, Kim JH, Brett-Major DM, Tovanabutra S.

Biomol Detect Quantif. 2019 Mar 11;17:100080. doi: 10.1016/j.bdq.2019.01.002. eCollection 2019 Mar.

5.

Transmission dynamics among participants initiating antiretroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand.

Kroon E, Pham PT, Sirivichayakul S, Trichavaroj R, Colby DJ, Pinyakorn S, Phanuphak N, Sanders-Buell E, van Griensven F, Kijak GH, Kim JH, Michael NL, Robb ML, Ananworanich J, De Souza MS, Tovanabutra S; RV254/SEARCH 010 Study Group.

AIDS. 2018 Oct 23;32(16):2373-2381. doi: 10.1097/QAD.0000000000001956.

PMID:
30096068
6.

Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones.

Chenine AL, Merbah M, Wieczorek L, Molnar S, Mann B, Lee J, OʼSullivan AM, Bose M, Sanders-Buell E, Kijak GH, Herrera C, McLinden R, OʼConnell RJ, Michael NL, Robb ML, Kim JH, Polonis VR, Tovanabutra S.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):348-355. doi: 10.1097/QAI.0000000000001675.

7.

Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Kijak GH, Sanders-Buell E, Chenine AL, Eller MA, Goonetilleke N, Thomas R, Leviyang S, Harbolick EA, Bose M, Pham P, Oropeza C, Poltavee K, O'Sullivan AM, Billings E, Merbah M, Costanzo MC, Warren JA, Slike B, Li H, Peachman KK, Fischer W, Gao F, Cicala C, Arthos J, Eller LA, O'Connell RJ, Sinei S, Maganga L, Kibuuka H, Nitayaphan S, Rao M, Marovich MA, Krebs SJ, Rolland M, Korber BT, Shaw GM, Michael NL, Robb ML, Tovanabutra S, Kim JH.

PLoS Pathog. 2017 Sep 14;13(9):e1006620. doi: 10.1371/journal.ppat.1006620. eCollection 2017 Sep.

8.

Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics.

Volz EM, Ndembi N, Nowak R, Kijak GH, Idoko J, Dakum P, Royal W, Baral S, Dybul M, Blattner WA, Charurat M.

Virus Evol. 2017 Jul 28;3(2):vex014. doi: 10.1093/ve/vex014. eCollection 2017 Jul.

9.

Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.

Kijak GH, Sanders-Buell E, Chenine AL, Eller MA, Goonetilleke N, Thomas R, Leviyang S, Harbolick EA, Bose M, Pham P, Oropeza C, Poltavee K, O'Sullivan AM, Billings E, Merbah M, Costanzo MC, Warren JA, Slike B, Li H, Peachman KK, Fischer W, Gao F, Cicala C, Arthos J, Eller LA, O'Connell RJ, Sinei S, Maganga L, Kibuuka H, Nitayaphan S, Rao M, Marovich MA, Krebs SJ, Rolland M, Korber BT, Shaw GM, Michael NL, Robb ML, Tovanabutra S, Kim JH.

PLoS Pathog. 2017 Jul 31;13(7):e1006510. doi: 10.1371/journal.ppat.1006510. eCollection 2017 Jul. Erratum in: PLoS Pathog. 2017 Sep 14;13(9):e1006620.

10.

Characteristics of HIV-infected U.S. Army soldiers linked in molecular transmission clusters, 2001-2012.

Hakre S, Jagodzinski LL, Liu Y, Pham PT, Kijak GH, Tovanabutra S, McCutchan FE, Scoville SL, Cersovsky SB, Michael NL, Scott PT, Peel SA.

PLoS One. 2017 Jul 31;12(7):e0182376. doi: 10.1371/journal.pone.0182376. eCollection 2017.

11.

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.

Gilbert PB, Excler JL, Tomaras GD, Carpp LN, Haynes BF, Liao HX, Montefiori DC, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Kijak GH, Tovanabutra S, Francis DP, Lee C, Sinangil F, Berman PW, Premsri N, Kunasol P, O'Connell RJ, Michael NL, Robb ML, Morrow R, Corey L, Kim JH.

PLoS One. 2017 May 11;12(5):e0176428. doi: 10.1371/journal.pone.0176428. eCollection 2017.

12.

HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania.

Billings E, Sanders-Buell E, Bose M, Kijak GH, Bradfield A, Crossler J, Arroyo MA, Maboko L, Hoffmann O, Geis S, Birx DL, Kim JH, Michael NL, Robb ML, Hoelscher M, Tovanabutra S.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):373-381. doi: 10.1089/AID.2016.0111. Epub 2016 Dec 19.

13.

Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG.

Heipertz RA Jr, Ayemoba O, Sanders-Buell E, Poltavee K, Pham P, Kijak GH, Lei E, Bose M, Howell S, OʼSullivan AM, Bates A, Cervenka T, Kuroiwa J, Akintunde A, Ibezim O, Alabi A, Okoye O, Manak M, Malia J, Peel S, Maisaka M, Singer D, O'Connell RJ, Robb ML, Kim JH, Michael NL, Njoku O, Tovanabutra S.

Medicine (Baltimore). 2016 Aug;95(32):e4346. doi: 10.1097/MD.0000000000004346.

14.

Centralized HIV Program Oversight: An Investigation of a Case Series of New HIV Infections among US Army Soldiers, 2012 to 2013.

Pacha LA, Hakre S, Myles O, Sanders-Buell EE, Scoville SL, Kijak GH, Price MW, Mody RM, Liu Y, Miller SL, Pham PT, Michael NL, Kim JH, Peel SA, Tovanabutra S, Jagodzinski LL, Cersovsky SB, Scott PT.

Medicine (Baltimore). 2015 Nov;94(46):e2093. doi: 10.1097/MD.0000000000002093. Erratum in: Medicine (Baltimore). 2016 Jan 22;95(3):e8498.

15.

The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.

Billings E, Sanders-Buell E, Bose M, Bradfield A, Lei E, Kijak GH, Arroyo MA, Kibaya RM, Scott PT, Wasunna MK, Sawe FK, Shaffer DN, Birx DL, McCutchan FE, Michael NL, Robb ML, Kim JH, Tovanabutra S.

PLoS One. 2015 Aug 19;10(8):e0135124. doi: 10.1371/journal.pone.0135124. eCollection 2015.

16.

HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.

Prentice HA, Tomaras GD, Geraghty DE, Apps R, Fong Y, Ehrenberg PK, Rolland M, Kijak GH, Krebs SJ, Nelson W, DeCamp A, Shen X, Yates NL, Zolla-Pazner S, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Ferrari G, McElrath MJ, Montefiori DC, Bailer RT, Koup RA, O'Connell RJ, Robb ML, Michael NL, Gilbert PB, Kim JH, Thomas R.

Sci Transl Med. 2015 Jul 15;7(296):296ra112. doi: 10.1126/scitranslmed.aab4005.

17.

An effective tool for identifying HIV-1 subtypes B, C, CRF01_AE, their recombinant forms, and dual infections in Southeast Asia by the multi-region subtype specific PCR (MSSP) assay.

Sakkhachornphop S, Kijak GH, Beyrer C, Razak MH, Sanders-Buell E, Jittiwutikarn J, Suriyanon V, Robb ML, Kim JH, Celentano DD, McCutchan FE, Tovanabutra S.

J Virol Methods. 2015 Jun 1;217:70-8. doi: 10.1016/j.jviromet.2015.02.015. Epub 2015 Feb 25.

PMID:
25725414
18.

Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.

Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, deCamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M, McCoy C, Larsen BB, Sanders-Buell E, Carrico C, Menis S, Kijak GH, Bose M; RV144 Sequencing Team, Arroyo MA, O'Connell RJ, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Rerks-Ngarm S, Robb ML, Kirys T, Georgiev IS, Kwong PD, Scheffler K, Pond SL, Carlson JM, Michael NL, Schief WR, Mullins JI, Kim JH, Gilbert PB.

PLoS Comput Biol. 2015 Feb 3;11(2):e1003973. doi: 10.1371/journal.pcbi.1003973. eCollection 2015 Feb. Erratum in: PLoS Comput Biol. 2016 Jan;12(1):e1004733.

19.

Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.

Gartland AJ, Li S, McNevin J, Tomaras GD, Gottardo R, Janes H, Fong Y, Morris D, Geraghty DE, Kijak GH, Edlefsen PT, Frahm N, Larsen BB, Tovanabutra S, Sanders-Buell E, deCamp AC, Magaret CA, Ahmed H, Goodridge JP, Chen L, Konopa P, Nariya S, Stoddard JN, Wong K, Zhao H, Deng W, Maust BS, Bose M, Howell S, Bates A, Lazzaro M, O'Sullivan A, Lei E, Bradfield A, Ibitamuno G, Assawadarachai V, O'Connell RJ, deSouza MS, Nitayaphan S, Rerks-Ngarm S, Robb ML, Sidney J, Sette A, Zolla-Pazner S, Montefiori D, McElrath MJ, Mullins JI, Kim JH, Gilbert PB, Hertz T.

J Virol. 2014 Aug;88(15):8242-55. doi: 10.1128/JVI.01164-14. Epub 2014 May 14.

20.

Targeted deep sequencing of HIV-1 using the IonTorrentPGM platform.

Kijak GH, Sanders-Buell E, Harbolick EA, Pham P, Chenine AL, Eller LA, Rono K, Robb ML, Michael NL, Kim JH, Tovanabutra S.

J Virol Methods. 2014 Sep 1;205:7-16. doi: 10.1016/j.jviromet.2014.04.017. Epub 2014 May 4.

21.

Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.

Sambor A, Garcia A, Berrong M, Pickeral J, Brown S, Rountree W, Sanchez A, Pollara J, Frahm N, Keinonen S, Kijak GH, Roederer M, Levine G, D'Souza MP, Jaimes M, Koup R, Denny T, Cox J, Ferrari G.

J Immunol Methods. 2014 Jul;409:107-16. doi: 10.1016/j.jim.2014.04.005. Epub 2014 Apr 29.

22.

Timing, adherence, resistance, and ... persistence? new insight into the mechanisms of failure of HIV type 1 postexposure prophylaxis.

Kijak GH, Kim JH.

J Infect Dis. 2013 Nov 15;208(10):1542-4. doi: 10.1093/infdis/jit486. Epub 2013 Sep 9. No abstract available.

23.

Natural killer cell-mediated innate sieve effect on HIV-1: the impact of KIR/HLA polymorphism on HIV-1 subtype-specific acquisition in east Africa.

Koehler RN, Alter G, Tovanabutra S, Saathoff E, Arroyo MA, Walsh AM, Sanders-Buell EE, Maboko L, Hoelscher M, Robb ML, Michael NL, McCutchan FE, Kim JH, Kijak GH.

J Infect Dis. 2013 Oct 15;208(8):1250-4. doi: 10.1093/infdis/jit349. Epub 2013 Aug 6.

24.

Nautilus: a bioinformatics package for the analysis of HIV type 1 targeted deep sequencing data.

Kijak GH, Pham P, Sanders-Buell E, Harbolick EA, Eller LA, Robb ML, Michael NL, Kim JH, Tovanabutra S.

AIDS Res Hum Retroviruses. 2013 Oct;29(10):1361-4. doi: 10.1089/AID.2013.0175. Epub 2013 Aug 2.

25.

Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Kijak GH, Tovanabutra S, Rerks-Ngarm S, Nitayaphan S, Eamsila C, Kunasol P, Khamboonruang C, Thongcharoen P, Namwat C, Premsri N, Benenson M, Morgan P, Bose M, Sanders-Buell E, Paris R, Robb ML, Birx DL, De Souza MS, McCutchan FE, Michael NL, Kim JH.

J Virol. 2013 Jul;87(13):7265-81. doi: 10.1128/JVI.03070-12. Epub 2013 Apr 10. Erratum in: J Virol. 2013 Dec;87(23):13084.

26.

Short communication: Investigation of incident HIV infections among U.S. army soldiers deployed to Afghanistan and Iraq, 2001-2007.

Scott PT, Hakre S, Myles O, Sanders-Buell EE, Kijak GH, McCutchan FE, O'Connell RJ, Peel SA, Eggleston JC, Sateren WB, Robb-McGrath M, Mott RL, Tobler SK, Nolan E, Petruccelli BP, Michael NL, Cersovsky SB.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1308-12. Epub 2012 Mar 13.

27.

Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.

Eller MA, Koehler RN, Kijak GH, Eller LA, Guwatudde D, Marovich MA, Michael NL, de Souza MS, Wabwire-Mangen F, Robb ML, Currier JR, Sandberg JK.

J Virol. 2011 May;85(10):4802-11. doi: 10.1128/JVI.00111-11. Epub 2011 Mar 16.

28.

Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: associations of risk with genetic complexity.

Kijak GH, Beyrer C, Tovanabutra S, Sripaipan T, Suriyanon V, Moqueet N, Sanders-Buell E, Saokhieo P, Timpan U, Jittiwutikarn J, Robb ML, Birx DL, Celentano DD, McCutchan FE.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):24-30. doi: 10.1016/j.drugalcdep.2010.11.013. Epub 2010 Dec 28.

PMID:
21193272
29.

High affinity allele for the gene of FCGR3A is risk factor for HIV infection and progression.

Poonia B, Kijak GH, Pauza CD.

PLoS One. 2010 Dec 20;5(12):e15562. doi: 10.1371/journal.pone.0015562.

30.

Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.

Steers NJ, Currier JR, Kijak GH, di Targiani RC, Saxena A, Marovich MA, Kim JH, Michael NL, Alving CR, Rao M.

J Virol. 2011 Feb;85(4):1541-53. doi: 10.1128/JVI.01790-10. Epub 2010 Nov 24.

31.

RecDraw: a software package for the representation of HIV-1 recombinant structures.

Kijak GH, Tovanabutra S, Beyrer C, Sanders-Buell EE, Arroyo MA, Robb ML, Michael NL, McCutchan FE, Kim JH.

AIDS Res Hum Retroviruses. 2010 Dec;26(12):1317-21. doi: 10.1089/aid.2010.0127. Epub 2010 Oct 21.

32.

Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania.

Koehler RN, Walsh AM, Saathoff E, Tovanabutra S, Arroyo MA, Currier JR, Maboko L, Hoelscher M, Robb ML, Michael NL, McCutchan FE, Kim JH, Kijak GH.

J Infect Dis. 2010 Nov 15;202(10):1562-6. doi: 10.1086/656913. Epub 2010 Oct 5. Erratum in: J Infect Dis. 2011 Mar;203(5):749. Hoelsher, Michael [corrected to Hoelscher, Michael].

PMID:
20923372
33.

HIV infection among U.S. Army and Air Force military personnel: sociodemographic and genotyping analysis.

Singer DE, Bautista CT, O'Connell RJ, Sanders-Buell E, Agan BK, Kijak GH, Hakre S, Sanchez JL, Sateren WB, McCutchan FE, Michael NL, Scott PT.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):889-94. doi: 10.1089/aid.2009.0289.

PMID:
20673143
34.

Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.

Saathoff E, Pritsch M, Geldmacher C, Hoffmann O, Koehler RN, Maboko L, Maganga L, Geis S, McCutchan FE, Kijak GH, Kim JH, Arroyo MA, Gerhardt M, Tovanabutra S, Robb ML, Williamson C, Michael NL, Hoelscher M.

J Acquir Immune Defic Syndr. 2010 Jul;54(3):324-30.

35.

High-throughput high-resolution class I HLA genotyping in East Africa.

Koehler RN, Walsh AM, Sanders-Buell EE, Eller LA, Eller M, Currier JR, Bautista CT, Wabwire-Mangen F, Hoelscher M, Maboko L, Kim J, Michael NL, Robb ML, McCutchan FE, Kijak GH.

PLoS One. 2010 May 20;5(5):e10751. doi: 10.1371/journal.pone.0010751.

36.

HIV type 1 molecular epidemiology among high-risk clients attending the Thai Red Cross Anonymous Clinic in Bangkok, Thailand.

Arroyo MA, Phanuphak N, Krasaesub S, Sirivichayakul S, Assawadarachai V, Poltavee K, Pankam T, Ananworanich J, Paris R, Tovanabutra S, Kijak GH, McCutchan FE, Phanuphak P, Kim JH, de Souza M.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):5-12. doi: 10.1089/aid.2009.0150.

PMID:
20055593
37.

High-throughput genotyping of KIR2DL2/L3, KIR3DL1/S1, and their HLA class I ligands using real-time PCR.

Koehler RN, Walsh AM, Moqueet N, Currier JR, Eller MA, Eller LA, Wabwire-Mangen F, Michael NL, Robb ML, McCutchan FE, Kijak GH.

Tissue Antigens. 2009 Jul;74(1):73-80. doi: 10.1111/j.1399-0039.2009.01265.x.

PMID:
19522772
38.

HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster.

Kijak GH, Walsh AM, Koehler RN, Moqueet N, Eller LA, Eller M, Currier JR, Wang Z, Wabwire-Mangen F, Kibuuka HN, Michael NL, Robb ML, McCutchan FE.

Tissue Antigens. 2009 Mar;73(3):262-9. doi: 10.1111/j.1399-0039.2008.01192.x.

PMID:
19254258
39.

Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells.

Kijak GH, Janini LM, Tovanabutra S, Sanders-Buell E, Arroyo MA, Robb ML, Michael NL, Birx DL, McCutchan FE.

Virology. 2008 Jun 20;376(1):101-11. doi: 10.1016/j.virol.2008.03.017. Epub 2008 Apr 24.

40.

Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand.

Tovanabutra S, Kijak GH, Beyrer C, Gammon-Richardson C, Sakkhachornphop S, Vongchak T, Jittiwutikarn J, Razak MH, Sanders-Buell E, Robb ML, Suriyanon V, Birx DL, Michael NL, Celentano DD, McCutchan FE.

AIDS Res Hum Retroviruses. 2007 Jun;23(6):829-33.

PMID:
17604547
41.

HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV.

Kijak GH, Janini M, Tovanabutra S, Sanders-Buell EE, Birx DL, Robb ML, Michael NL, McCutchan FE.

AIDS Res Hum Retroviruses. 2007 Apr;23(4):554-7.

PMID:
17451344
42.

Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.

Kijak GH, Tovanabutra S, Sanders-Buell E, Watanaveeradej V, de Souza MS, Nelson KE, Ketsararat V, Gulgolgarn V, Wera-arpachai M, Sriplienchan S, Khamboonrueng C, Birx DL, Robb ML, McCutchan FE.

Virology. 2007 Feb 5;358(1):178-91. Epub 2006 Sep 25.

43.

HIV diversity, molecular epidemiology, and the role of recombination.

Kijak GH, McCutchan FE.

Curr Infect Dis Rep. 2005 Nov;7(6):480-8.

PMID:
16225787
44.

Development and application of a high-throughput HIV type 1 genotyping assay to identify CRF02_AG in West/West Central Africa.

Kijak GH, Sanders-Buell E, Wolfe ND, Mpoudi-Ngole E, Kim B, Brown B, Robb ML, Birx DL, Burke DS, Carr JK, McCutchan FE.

AIDS Res Hum Retroviruses. 2004 May;20(5):521-30.

PMID:
15186527
45.

Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistance.

Kijak GH, Currier JR, Tovanabutra S, Cox JH, Michael NL, Wegner SA, Birx DL, McCutchan FE.

AIDS Rev. 2004 Jan-Mar;6(1):54-60. Review.

PMID:
15168741
46.

Differences in frequencies of drug resistance-associated mutations in the HIV-1 pol gene of B subtype and BF intersubtype recombinant samples.

Carobene MG, Rubio AE, Carrillo MG, Maligne GE, Kijak GH, Quarleri JF, Salomón H.

J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):207-9. No abstract available.

PMID:
14722457
47.

Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.

Kijak GH, Rubio AE, Pampuro SE, Zala C, Cahn P, Galli R, Montaner JS, Salomón H.

HIV Med. 2003 Jan;4(1):72-8.

48.

Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.

Kijak GH, Simon V, Balfe P, Vanderhoeven J, Pampuro SE, Zala C, Ochoa C, Cahn P, Markowitz M, Salomon H.

J Virol. 2002 Jul;76(14):7000-9.

49.

HIV type 1 genetic diversity is a major obstacle for antiretroviral drug resistance hybridization-based assays.

Kijak GH, Rubio AE, Quarleri JF, Salomón H.

AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1415-21.

PMID:
11679154
50.

Mother-to-child transmission of drug-resistant HIV.

Kijak GH, Avila MM, Salomón H.

Drug Resist Updat. 2001 Feb;4(1):29-37. Review.

PMID:
11512150

Supplemental Content

Loading ...
Support Center